S68F (p.Ser68Phe) variant of AGT (Angiotensinogen)
S68F (p.Ser68Phe) in AGT (Angiotensinogen) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.44 / 1. The record also includes population frequency data and structural context.
S68F (p.Ser68Phe) variant details
- p.Ser68Phe
- rs753775475
- ExAC rs753775475
- gnomAD rs753775475
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.437
- AlphaMissense 0.15
- MetaLR 0.42
- MetaSVM -0.45
- PolyPhen-2 0.24
- SIFT 0.03
- MutPred 0.34
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available